Internal Medicine, Rheumatology · Loxahatchee, FL
NPI
1245295377
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
12977 Southern Blvd Ste 200
Loxahatchee, FL, 33470
Phone (561) 798-8184
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.8M
121,818 services
Medicare patients, 2024
527
Average age 72
Drug cost, 2024
$3.8M
3,093 prescriptions
Company payments, 2025
$32K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christine N Savage was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 48,800 times for 20 patients. In total Christine N Savage billed 121,818 services in 75 codes, and Medicare paid $1.8M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 48,800 | 20 | $3.57 | $174K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 23,100 | 28 | $8.52 | $197K |
| J0897 Injection, denosumab, 1 mg | Office | 6,960 | 83 | $20.43 | $142K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 4,800 | 17 | $32.95 | $158K |
| 99214 Office E&M - Established | Office | 787 | 411 | $100.71 | $79K |
| 96401 Chemotherapy Administration | Office | 557 | 124 | $59.70 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 481 | 270 | $13.98 | $6,723 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 379 | 23 | $0.11 | $40.58 |
| 96413 Chemotherapy Administration | Office | 234 | 58 | $109.32 | $26K |
| 99215 Office E&M - Established | Office | 117 | 76 | $147.13 | $17K |
| 73130 X-ray - Upper Extremity | Office | 104 | 55 | $31.00 | $3,224 |
| 96415 Chemotherapy Administration | Office | 78 | 15 | $23.18 | $1,808 |
| 73630 X-ray - Lower Extremity | Office | 68 | 37 | $29.41 | $2,000 |
| 73110 X-ray - Upper Extremity | Office | 61 | 31 | $35.30 | $2,154 |
| 99204 Office E&M - New | Office | 60 | 60 | $137.37 | $8,242 |
By year: 2022 $1.6M for 87,873 services; 2023 $2.2M for 144,319 services; 2024 $1.8M for 121,818 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christine N Savage prescribed most often to Medicare patients was Prednisone, with 292 prescriptions and refills. In total Christine N Savage wrote 3,093 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 292 | 468 | 86 | $1,988 |
| Hydroxychloroquine Sulfate Generic | 283 | 657 | 94 | $8,365 |
| Methotrexate Methotrexate Sodium | 160 | 270 | 55 | $2,356 |
| Sulfasalazine Generic | 136 | 256 | 55 | $2,317 |
| Gabapentin Generic | 125 | 241 | 40 | $1,604 |
| Tizanidine Hcl Generic | 111 | 168 | 46 | $766 |
| Tramadol Hcl Generic | 110 | 119 | 33 | $761 |
| Celecoxib Generic | 102 | 191 | 42 | $3,575 |
| Pregabalin Generic | 102 | 138 | 24 | $2,238 |
| Leflunomide Generic | 101 | 210 | 35 | $4,272 |
| Topiramate Generic | 78 | 164 | 26 | $763 |
| Duloxetine Hcl Generic | 66 | 146 | 24 | $1,300 |
| Methylprednisolone Generic | 62 | 87 | 27 | $644 |
| Clonazepam Generic | 57 | 69 | 13 | $290 |
| Allopurinol Generic | 55 | 137 | 20 | $372 |
Brand drugs: - claims; generic drugs: 2,624 claims; opioid claims: 116.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christine N Savage $32K ($32K in general payments such as food, travel and fees) from 17 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $28K.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 42 | $28K |
| Amgen Inc. AMGN | 78 | $1,053 |
| Abbvie Inc. ABBV | 29 | $534 |
| Novartis Pharmaceuticals Corporation NVS | 22 | $434 |
| UCB, Inc. UCB.BR | 28 | $423 |
| ANI Pharmaceuticals, Inc. ANIP | 21 | $370 |
| GlaxoSmithKline, LLC. GSK | 11 | $337 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $297 |
| Pfizer Inc. PFE | 21 | $259 |
| Janssen Biotech, Inc. JNJ | 7 | $160 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.